Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

By Tricoli J.V.   Winter D.L.   Hanlon A.L.   Raysor S.L.   Watkins-Bruner D.   Pinover W.H.   Hanks G.E.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 178-182

Elsevier

Access to resources Recommend Favorite

Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men

By Sarma A.V.   Jaffe C.A.   Schottenfeld D.   Dunn R.   Montie J.E.   Cooney K.A.   Wei J.T.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 362-367

Elsevier

Access to resources Recommend Favorite

Insulin-Like Growth Factor Binding Protein-3 Inhibits Colitis-Induced Carcinogenesis

By Belizon A.   Balik E.   Kirman I.   Remotti H.   Ciau N.   Jain S.   Whelan R.  

Diseases of the Colon & Rectum, Vol. 50, Iss. 9, 2007-09 ,pp. : 1377-1383

Springer Publishing Company

Access to resources Recommend Favorite

Insulin-like growth factor I and prostate cancer

By O'Brien M.F.   Watson R.W.G.   Fitzpatrick J.M.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Insulin-like growth factor-I increases p21 expression and attenuates cisplatin-induced acute renal injury in rats

By Yasuda Hideo   Kato Akihiko   Miyaji Takehiko   Zhou Hua   Togawa Akashi   Hishida Akira  

Clinical and Experimental Nephrology, Vol. 8, Iss. 1, 2004-03 ,pp. : 27-35

Springer Publishing Company

Access to resources Recommend Favorite